gvtcx

supplier · GB-PPONPPDW-8775-RCQV

Gilead Sciences Ltd

WC1V7EE combined from 2 published records

Gilead Sciences Ltd has won 67 UK public sector awards from 16 buyers since 2017. The typical award is worth £115,600,000.

as a supplier

67 recorded awards from 16 buyers , between 10 Aug 2017 and 26 Aug 2026.

awards won
67
exclusive
52%
35 sole-winner awards
median award
£115.6m
largest
£480.4m

“Exclusive” means this organisation was the only one awarded under that procurement; the rest were shared with other suppliers, typically on a framework.

sells to

common questions about Gilead Sciences Ltd

How many public sector contracts has Gilead Sciences Ltd won?

Gilead Sciences Ltd has won 67 UK public sector contracts from 16 public bodies since 2017.

Which public bodies buy from Gilead Sciences Ltd?

Gilead Sciences Ltd has won the most contracts from NHS England, The Common Services Agency (more commonly known as NHS National Services Scotland) ("NSS") and Department of Health and Social Care (DHSC).

How large are Gilead Sciences Ltd's contracts?

The median published value of a contract won by Gilead Sciences Ltd is £115,600,000. Framework ceilings are excluded, because they state a spending limit shared across many suppliers rather than a value one supplier received.

Which Gilead Sciences Ltd contracts are expiring soon?

1 contract involving Gilead Sciences Ltd has an end date in the next 12 months, the earliest on 31 Oct 2026.

contracts expiring in the next 12 months

Contract end dates as published on the original notice. An end date is not a commitment to re-tender — a contract may be extended, varied or allowed to lapse — but it is the earliest public signal that work may come back to market.

contracts won

contractbuyervalueawarded
NHS National Generic Pharmaceuticals - Wave 16a shared NHS England £393,331,872 26 Aug 2026
REMDESIVIR INFUSION Southern Health and Social Care Trust £300,000 28 Apr 2026
Biktarvy Southern Health and Social Care Trust £1,200,000 27 Apr 2026
NHS England procurement for the supply of Pan-genotypic Direct Acting Antiviral (DAA) Hepatitis C treatments and the provision of Hepatitis C elimination initiatives shared NHS England £160,000,000 25 Feb 2026
NHS Framework for the supply of Licensed Antiretroviral Therapy (ART) 1 Nov 2024 shared NHS England £626,522,476 28 Oct 2024
NHS National Framework for Transition products commencing 1 October 2024 shared NHS England £16,224,000 29 Sept 2024
NHS London Branded Medicines - Tranche B - September 2023 shared NHS ENGLAND £231,083,000 13 Jul 2023
NHS Midland & East Branded Medicines, Tranche B & Annual Tranche shared NHS England £480,429,000 13 Feb 2023
Supply of Remdesivir Department of Health and Social Care (DHSC) £17,334,000 30 Mar 2022
Supply of Remdesivir Department of Health and Social Care (DHSC) £5,739,200 28 Feb 2022
NHS Framework for the North of England, Branded Medicine shared NHS England £238,913,892 7 Feb 2022
National Procurement for HIV and Preventative Treatments shared NHSE&I £230,000,000 1 Feb 2022
Supply of Remdesivir Department of Health and Social Care (DHSC) £7,432,401 16 Dec 2021
NHS Framework Agreement, Branded Medicines for London and South of England shared NHS England £558,521,926 18 Aug 2021
Supply of Remdesivir Department of Health and Social Care (DHSC) £7,477,440 21 Jan 2021
Supply of Remdesivir Department of Health and Social Care (DHSC) £21,535,027 15 Jan 2021
Supply of Remdesivir Department of Health and Social Care (DHSC) £7,776,538 11 Jan 2021
Supply of Remdesivir Department of Health and Social Care (DHSC) £3,813,494 5 Jan 2021
Supply of Remdesivir Department of Health and Social Care (DHSC) £9,257,100 10 Nov 2020
Supply of Remdesivir Department of Health and Social Care (DHSC) £11,543,260 10 Nov 2020
Supply of Remdesivir Department of Health and Social Care (DHSC) £21,330,073 5 Nov 2020
Contract for the Supply of Remdesivir Department of Health and Social Care (DHSC) £21,455,873 12 Oct 2020
NHS Framework Agreement - Hepatitis C Medicines shared NHS England £180,000,000 15 Apr 2018
NHS Framework Agreement - North of England - Tranche B shared NHS England £521,100,000 8 Jan 2018
NHS England Framework Agreement: Midlands and East (Tranche A) shared NHS England £163,000,000 8 Jan 2018

every contract won by Gilead Sciences Ltd →

as published

This page combines 2 separate records from the source data. Every one is listed below exactly as the publisher filed it, so you can check the grouping yourself.

name as publishedidentifierpostcoderecords
Gilead Sciences Limited · WC1V 7EE 61
Gilead Sciences Limited GB-PPON PPDW-8775-RCQV WC1V 7EE 6

why these were combined

Matching uses organisation identifiers where publishers provide them, falling back to name and address. Records are never combined on address alone, because one shared-service postcode carries 244 different organisations. how this works

where these figures come from

Every figure on this page is derived from notices published by Contracts Finder, Find a Tender, Public Contracts Scotland and Sell2Wales, under the Open Government Licence v3.0. The corpus runs from 17 Dec 2014 to 11 Sept 2026 and is refreshed from the publishers' own APIs through the working day.

Records are combined into one organisation on identifiers where publishers provide them — a Companies House number, a GB-PPON supplier id — and on exact normalised name and address where they do not. Never on address alone: one shared-service postcode carries 244 unrelated organisations. The 2 published records behind this page are listed above exactly as filed, so any merge can be checked.

Counts are of contracting processes, not published notices: a tender and its award notice are one contract, and are counted once. Values are medians, never totals, and exclude framework ceilings — a ceiling states a spending limit shared across every supplier on the framework, so adding them together produces a number no one ever spent. sources and coverage · how matching works

Contains public sector information licensed under the Open Government Licence v3.0.